In the first half of 2020, Jianhe's revenue of 5.167 billion yuan in milk powder online business has increased significantly

Published Aug 26, 2020

Tridge summary

H&H International Holdings Co., Ltd. (Jianhe Group) has reported a 2.6% increase in revenue to 5.167 billion yuan for the first half of 2020, with an 8.9% increase in adjusted net profit to 658 million yuan. The company resumed production in China and maintained normal production in French and Australian factories amid the pandemic. There was a significant growth in the sales of immunity-related products, with a 45.4% year-on-year increase in the BNC category and a 48.5% increase in the ANC category. The Chinese market saw a 12.8% year-on-year growth, contributing 82.6% to the total revenue. Jianhe Group also donated over RMB 10 million for anti-epidemic aid and was upgraded to 'BBB' in the MSCI index environmental, social, and governance rating.

Disclaimer: The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

China Food Safety Net News (Reporter Niu Chun'an) On August 25th, we are committed to becoming a global leader in the high-end nutrition and health industry-H&H International Holdings Co., Ltd. (stock code: HK.1112, hereinafter referred to as "Jianhe Group" ), officially announced the performance data for the first half of 2020. In the first half of 2020, the group's revenue reached 5.167 billion yuan, a year-on-year increase of 2.6%, and adjusted net profit increased by 8.9% to 658 million yuan. The group’s operating cash flow increased by 25.4% year-on-year, sufficient The Group’s cash balance and stable cash flow better support the Group’s response to challenges and help the Group’s steady and long-term development. Join forces to fight the epidemic to ensure supply to meet demand and take advantage of the trend of the outbreak of the new crown pneumonia epidemic in early 2020. The group immediately launched an emergency plan for epidemic prevention and production. Under the ...

Source: CFSN